Short Interest in Genesis Healthcare Inc (NYSE:GEN) Declines By 8.2%

Genesis Healthcare Inc (NYSE:GEN) saw a large drop in short interest during the month of June. As of June 30th, there was short interest totalling 3,146,200 shares, a drop of 8.2% from the May 30th total of 3,426,000 shares. Based on an average daily volume of 244,600 shares, the short-interest ratio is currently 12.9 days. Approximately 6.1% of the shares of the company are short sold.

Large investors have recently added to or reduced their stakes in the company. Citigroup Inc. lifted its holdings in shares of Genesis Healthcare by 74.3% during the 4th quarter. Citigroup Inc. now owns 34,936 shares of the company’s stock worth $41,000 after acquiring an additional 14,893 shares during the period. BlackRock Inc. lifted its holdings in shares of Genesis Healthcare by 0.7% during the 4th quarter. BlackRock Inc. now owns 3,250,648 shares of the company’s stock worth $3,835,000 after acquiring an additional 24,163 shares during the period. California Public Employees Retirement System lifted its holdings in shares of Genesis Healthcare by 8.4% during the 4th quarter. California Public Employees Retirement System now owns 383,258 shares of the company’s stock worth $452,000 after acquiring an additional 29,807 shares during the period. Millennium Management LLC lifted its holdings in shares of Genesis Healthcare by 79.5% during the 4th quarter. Millennium Management LLC now owns 535,970 shares of the company’s stock worth $632,000 after acquiring an additional 237,370 shares during the period. Finally, Mackay Shields LLC bought a new position in shares of Genesis Healthcare during the 4th quarter worth about $59,000. 21.34% of the stock is owned by institutional investors.

NYSE GEN traded down $0.04 during midday trading on Monday, hitting $1.19. The company had a trading volume of 159,322 shares, compared to its average volume of 215,315. The firm has a market cap of $194.15 million, a PE ratio of -0.77 and a beta of 1.03. The stock has a fifty day moving average of $1.22. Genesis Healthcare has a fifty-two week low of $1.10 and a fifty-two week high of $1.81.

Genesis Healthcare (NYSE:GEN) last released its quarterly earnings data on Thursday, May 9th. The company reported ($0.15) EPS for the quarter, topping analysts’ consensus estimates of ($0.25) by $0.10. The business had revenue of $1.16 billion for the quarter, compared to the consensus estimate of $1.17 billion. Equities research analysts forecast that Genesis Healthcare will post -0.74 EPS for the current fiscal year.

Genesis Healthcare Company Profile

Genesis Healthcare, Inc, together with its subsidiaries, owns and operates skilled nursing facilities and assisted/senior living facilities in the United States. The company operates through three segments: Inpatient Services, Rehabilitation Therapy Services, and All Other Services. It also provides a range of rehabilitation therapy services, including speech-language pathology, physical therapy, occupational therapy, and respiratory therapy.

Featured Article: If I purchase shares through a brokerage account, am I the holder of record?

Receive News & Ratings for Genesis Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genesis Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.